| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fbcf2447ee461074ee7604a82810cd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e889829b99b0120417b45e646a2d5c0a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-099
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-10 |
| filingDate |
2019-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfba5c902606e3fa70e006456db7357b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_406f44ccd2a8c2f7ceed9193166b4ff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e77df28a46d9708d8d8603399ec834f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1acf59e74a108b34b44fb0fa285a7ef3 |
| publicationDate |
2020-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111819184-A |
| titleOfInvention |
Synthetic oligosaccharide derivatives as vaccines against Bordet pertussis |
| abstract |
The present invention provides a synthetic oligosaccharide fragment based on the terminal pentasaccharide of Bordetella pertussis lipo-oligosaccharide, and a method for obtaining the synthetic oligosaccharide fragment and its conjugate. Also provided are vaccine compositions containing such glycoconjugates that elicit an immune response that reduces nasopharyngeal colonization by B. pertussis. |
| priorityDate |
2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |